Clinical Trial Update: Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

View source ↗

Summary

A completed clinical trial evaluated whether urinary Kidney Injury Molecule-1 (KIM-1) excretion can serve as a biomarker for injury in kidney transplant recipie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Dysfunction

Snippet

Sponsor: Northwell Health | Conditions: Kidney Transplant Dysfunction | Status: COMPLETED